4-Aminobiphenyl and Cancer

4-Aminobiphenyl is an aromatic amine. That means a ring-shaped carbon compound with a nitrogen group attached. Its CAS registry number is 92-67-1. Older papers call it para-aminodiphenyl or xenylamine. At room temperature it is a colorless solid with a floral smell.

It matters for one reason. Very few chemicals were shown to cause human cancer before anyone tested them in animals. This is one of them. The proof came from the men who made it.

A study published in the mid-1950s looked at one plant that made the chemical. Of 171 workers there, 19 developed bladder cancer. That is 11%. The men had been exposed for 1.5 to 19 years, between 1935 and 1955.

That finding started an effort to stop making and using it. Later work made the case stronger:

• From 1955, 541 exposed workers were followed for 14 more years. Forty-three of them developed bladder cancer confirmed under a microscope. That is 7.9%.
• A survey at another chemical plant found bladder cancer death risk raised tenfold. Every man who died of bladder cancer there had worked at the plant between 1941 and 1952. Those were the years the plant used 4-aminobiphenyl.

IARC judged the human evidence sufficient. It said so in 1972 and again in 1987. The National Toxicology Program calls the chemical known to be a human carcinogen. It appeared in the first Annual Report on Carcinogens, in 1980.

Animal work later matched the human data. Given by mouth, it caused bladder cancer in mice, rabbits, and dogs. In mice it also caused liver tumors and angiosarcoma, a cancer of blood vessels. Injected under the skin of rats, it caused breast and intestinal tumors.

NTP describes the mechanism as one that needs the body's help. The compound has to be changed into a reactive form before it does its worst damage.

Liver enzymes in the cytochrome P450 family add an oxygen and hydrogen pair to the nitrogen. That step is called N-hydroxylation. The changed molecule can stick to blood proteins such as hemoglobin and travel around the body. It can also change again into reactive pieces. Those pieces reach the bladder and bind straight to DNA there. Bound pieces like this are called DNA adducts. They have been found in bladder lining cells from exposed dogs and from exposed people.

A second pathway disarms the chemical instead. It is called N-acetylation. How fast you do it is partly inherited. Some people are slow acetylators, meaning they carry a weak form of the enzyme. Among smokers, slow acetylators end up with more of the chemical stuck to their hemoglobin. Fast acetylators end up with less. Same cigarettes, different inner dose.

Commercial production in the United States ended in the mid-1950s. Today the compound is used only in laboratory research. Lab technicians and scientists are the workers most at risk.

For everyone else, one route is left: tobacco smoke. The amounts have been measured.

• Mainstream smoke, unfiltered cigarettes: 2.4 to 4.6 nanograms per cigarette.
• Mainstream smoke, filtered cigarettes: 0.2 to 23 nanograms per cigarette.
• Sidestream smoke, which rises off the burning tip: up to 140 nanograms per cigarette.

That last line matters most for anyone who shares air with a smoker. Sidestream smoke can carry far more of this chemical than the smoke a smoker draws in.

This is one thread in a thick rope. Bladder cancer is 2 to 10 times more common in smokers than in nonsmokers. 4-Aminobiphenyl is only one of several bladder carcinogens in smoke. The wider picture is in our page on tobacco and cancer.

This chemical also has a color-additive history that is easy to miss.

It turned up as a contaminant in the color additive D&C yellow no. 1. That additive was dropped in the late 1970s. Ext. D&C yellow no. 1 is banned outright because of the same contamination. FDA allows FD&C yellow no. 5, FD&C yellow no. 6, and D&C red no. 33 to carry traces. The limits run from 5 to 275 parts per billion.

For scale, look at what testing found before those limits. Ten FDA-certified samples of D&C red no. 33 from 1983 held 151 to 856 parts per billion. The average was 567. An eleventh sample held more than 6,500 parts per billion, and the maker withdrew it.

Four federal laws and two workplace bodies name this chemical:

• Clean Air Act. Listed as a hazardous air pollutant.
• CERCLA. Reportable quantity is 1 pound. Spilling more triggers a federal report.
• Community Right-To-Know Act. Covered by Toxics Release Inventory reporting.
• Resource Conservation and Recovery Act. Listed as a hazardous waste constituent.
• OSHA. Treated as a potential job carcinogen. Engineering controls, work practices, and protective equipment are required.
• ACGIH and NIOSH. ACGIH sets no number. Its guidance is that exposure by every route be as low as possible. NIOSH lists it as a potential job carcinogen.

The controls appear to work. EPA's Toxics Release Inventory listed only one facility reporting releases. Those ran from 2 to 48 pounds a year between 1988 and 2001. None were reported in 1997 or 1998. Most went to deep injection wells.

Bladder cancer is not rare. The American Cancer Society projects 84,530 new cases in the United States in 2026, a figure SEER carries. That is 4.0% of all cancer diagnoses, with 17,870 deaths. About 2.1% of people are diagnosed at some point in life.

Almost none of that burden now traces back to factory 4-aminobiphenyl. That exposure was removed 70 years ago. The share still worth preventing arrives by cigarette. So the single action that lowers your dose of this chemical is not smoking, and not breathing other people's smoke.

Want the words behind the labels? Start with what a carcinogen is. A close cousin with the same factory history is benzidine. For the disease itself, see bladder cancer.

• National Toxicology Program, Report on Carcinogens, 15th Edition: 4-Aminobiphenyl, accessed August 6, 2026
• National Cancer Institute SEER Program, Cancer Stat Facts: Bladder Cancer, accessed August 6, 2026